Ottobock SE & Co. KGaA
ISIN: DE000BCK2223
WKN: BCK222
13 May 2026 08:22AM

EQS-Adhoc: Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

Ottobock SE & Co. KGaA · ISIN: DE000BCK2223 · EQS - adhoc news
Country: Germany · Primary market: Germany · EQS NID: 2326622

EQS-Ad-hoc: Ottobock SE & Co. KGaA / Key word(s): Mergers and Acquisitions / Purchase of parts of a company
Ottobock SE & Co. KGaA: Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

13-May-2026 / 08:22 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Disclosure of inside information in accordance with Article 17 of (EU) Regulation No. 596/2014:

Ottobock acquires patient care business from Blatchford in Norway for approximately € 110 million

Duderstadt, 13 May 2026

 

Ottobock SE & Co. KGaA SE & Co. KGaA (ISIN: DE000BCK2223) (Ottobock) today concluded a purchase agreement with Blatchford Ltd., UK, (Blatchford) to acquire Blatchford Norway A/S (Blatchford Norway) for a purchase price of approximately € 110 million.

The acquisition encompasses the Norwegian patient care business of Blatchford with eight locations and around 200 employees. The total revenue of Blatchford Norway most recently amounted to around € 40 million. Based on the existing profitability of the business as well as expected synergies, the acquisition will remain at the Ottobock’s Group profitability level.

By acquiring Blatchford Norway, Ottobock is further expanding its international Patient Care network, which includes more than 420 locations to date. Ottobock has not been represented with its own locations in the Norwegian market up to now. With this acquisition, the company strategically closes a gap in the European market and is consistently following its acquisition strategy of acquiring leading patient care companies and integrating them into its international network. This is being done in particular because close cooperation between operating doctors/hospitals, rehabilitation centres and O&P Patient Care clinics is becoming increasingly important due to technological developments in the orthosis & prosthesis (O&P) industry.

The transaction will be closed as planned within the next few days.

 

Investor contact:

Ottobock SE & Co. KGaA
Julia Hartmann
VP Investor Relations
Mobile +49 151 556 848 07
Julia.Hartmann@ottobock.de
 

 



End of Inside Information

13-May-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Ottobock SE & Co. KGaA
Max-Näder-Straße 15
37115 Duderstadt
Germany
Phone: +49 5527 848 - 0
E-mail: info@ottobock.com
Internet: https://corporate.ottobock.com
ISIN: DE000BCK2223
WKN: BCK222
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; Vienna Stock Exchange
EQS News ID: 2326622

 
End of Announcement EQS News Service

2326622  13-May-2026 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2020 2021 2022 2023 2024 2025 2026e
Sales1 0,00 1.187,51 1.333,19 1.495,04 1.604,60 1.679,80 1.790,00
EBITDA1,2 0,00 162,12 1.963,35 248,70 299,20 371,80 440,00
EBITDA-Margin3 0,00 0,00 14,85 16,64 18,65 22,13 24,58
EBIT1,4 0,00 0,00 -934,00 -27,00 290,00 0,00 256,00
EBIT-Margin5 0,00 0,00 0,00 -1,81 18,07 11,07 14,30
Net Profit (Loss)1 0,00 19,63 75,33 48,10 27,90 88,30 140,00
Net-Margin6 0,00 0,00 5,64 3,22 1,74 5,26 7,82
Cashflow1,7 0,00 0,00 82,00 197,80 275,10 333,20 0,00
Earnings per share8 0,00 0,00 1,17 0,75 0,44 1,44 2,10
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,97 1,05
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: KPMG

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Ottobock
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
BCK222 DE000BCK2223 SE & Co. KGaA 3.269,90 Mio € 09.10.2025 9F3GG68Q+78
* * *
PE 2027e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
21,29 24,33 0,88 39,31 9,97 9,81 1,95
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,97 1,90%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
19.05.2026 06.05.2026 13.08.2026 12.11.2026 19.03.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+0,59%
51,10 €
ATH 76,35 €
-7,91% +0,00% -21,69% +0,00% -22,58%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL